Combination of azacitidine and lenalidomide in myelodysplastic syndromes or acute myeloid leukemia-a wise liaison?
about
Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.Clinical development of demethylating agents in hematologyClinical utility of lenalidomide in the treatment of myelodysplastic syndromesExpanding role of lenalidomide in hematologic malignanciesSequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study.Epigenetics of myelodysplastic syndromes.Epigenetics in the hematologic malignancies.The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes.Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications.Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson.Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML.Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients
P2860
Q30235355-B6F6BAA2-3BC8-4C65-A24B-1C9AFE3D7E16Q34395179-7DAEEC02-5E8E-4636-B375-47E8C6AE6CD6Q34783754-1E0CFBF1-4AA3-49E9-B21E-2D938A4E216CQ35592305-03E17B50-5F3E-41E7-BCC7-58015312D2CEQ37074311-41FFE793-6839-4690-96E1-6EEBA1968817Q38163846-77C69353-8CBC-4ED5-9D3B-DDE3362F96A8Q38282809-126B4A9D-1D95-4189-95DE-3614509FA610Q38570399-D2F54743-8E9D-42C5-B815-5471E1D4CC90Q38758162-EA083E54-FDC9-4355-81E8-29E50CE2F9A4Q41080080-99A782EB-A707-4EBC-B6F3-A2EDA473BEA6Q41939573-7CAB98BC-350F-4D87-81A3-83C817B625EBQ55515597-B594D535-AC30-4C9D-AAB8-C834B9E73D39Q56974946-4B9A4255-5F01-4DD4-97F5-45563DE312D6
P2860
Combination of azacitidine and lenalidomide in myelodysplastic syndromes or acute myeloid leukemia-a wise liaison?
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@ast
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@en
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@nl
type
label
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@ast
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@en
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@nl
prefLabel
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@ast
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@en
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@nl
P2860
P356
P1433
P1476
Combination of azacitidine and ...... eloid leukemia-a wise liaison?
@en
P2093
U Platzbecker
P2860
P2888
P304
P356
10.1038/LEU.2013.140
P577
2013-05-06T00:00:00Z
P6179
1008273949